retatrutide effects clinical trial retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Side Effects: What Patients

Lilly granted one person extraordinary access to its next-gen drug Eli Lilly and the FDA have allowed one person to receive the pharma companys highly promising obesity candidate through the agencys compassionate use program, my colleague Lizzy Lawrence exclusively reports

And you're exactly who we're here to help

Next-generation drugs like retatrutide (25-30% weight loss in trials) may arrive in 2027-2028 but are not available today

Ethical approval was obtained from the Ethical Committees of the Oulu University Hospital (decision #29/2011, amendment 2/24/2014) and Kuopio University Hospital (decision #79 #73/2016)